Biophysical and Structural Biology Methods Enable Fragment-Based Ligand Discovery
Published on 10-25-202311:34 AM by
a_borsuk| Updated on 10-25-202311:35 AM
Powerful biophysical and structural biology tools enable the study of large numbers of fragments and are opening up new possibilities in the treatment of various diseases. Here we report the results of a conventional and a covalent Fragment Screening and show how orthogonal biophysical and structural methods enable rapid identification, characterization, and optimization of fragments.
Key Learning Objectives:
Covalent & Conventional FBDD as an Integrated Service in Wuxi Biology
Available Fragment Libraries
Established Screening Workflow & Screening Technologies
Structure Determination for Fragments
Hit Expansion & Med Chem Capabilities
Case Studies to Highlight Capabilities
Who Should Attend:
CSO, Senior Scientist, MedChem experts & all scientist interested in FBDD as well as discovery of covalent inhibitors
Brought to you by:
Speakers:
Moran Jerabek-Willemsen, PhD Head of Biophysics & Screening, WuXi Biology
Catherine Dold Health & Environment Writer, C&EN Media Group